173 related articles for article (PubMed ID: 29130895)
1. Ceramic core with polymer corona hybrid nanocarrier for the treatment of osteosarcoma with co-delivery of protein and anti-cancer drug.
Prasad SR; Kumar TSS; Jayakrishnan A
Nanotechnology; 2018 Jan; 29(1):015101. PubMed ID: 29130895
[TBL] [Abstract][Full Text] [Related]
2. Combinational delivery of anticancer drugs for osteosarcoma treatment using electrosprayed core shell nanocarriers.
Prasad SR; Jayakrishnan A; Kumar TSS
J Mater Sci Mater Med; 2020 May; 31(5):44. PubMed ID: 32367204
[TBL] [Abstract][Full Text] [Related]
3. Poloxamer surface modified trimethyl chitosan nanoparticles for the effective delivery of methotrexate in osteosarcoma.
Li S; Xiong Y; Zhang X
Biomed Pharmacother; 2017 Jun; 90():872-879. PubMed ID: 28449430
[TBL] [Abstract][Full Text] [Related]
4. Folic acid conjugated bovine serum albumin: An efficient smart and tumor targeted biomacromolecule for inhibition folate receptor positive cancer cells.
Nosrati H; Abbasi R; Charmi J; Rakhshbahar A; Aliakbarzadeh F; Danafar H; Davaran S
Int J Biol Macromol; 2018 Oct; 117():1125-1132. PubMed ID: 29885392
[TBL] [Abstract][Full Text] [Related]
5. Anticancer effect of X-Ray triggered methotrexate conjugated albumin coated bismuth sulfide nanoparticles on SW480 colon cancer cell line.
Faghfoori MH; Nosrati H; Rezaeejam H; Charmi J; Kaboli S; Johari B; Danafar H
Int J Pharm; 2020 May; 582():119320. PubMed ID: 32278720
[TBL] [Abstract][Full Text] [Related]
6. Bio-modified carbon nanoparticles loaded with methotrexate possible carrier for anticancer drug delivery.
Muthukumar T; Prabhavathi S; Chamundeeswari M; Sastry TP
Mater Sci Eng C Mater Biol Appl; 2014 Mar; 36():14-9. PubMed ID: 24433881
[TBL] [Abstract][Full Text] [Related]
7. Preparation and In Vitro/In Vivo Characterization of Polymeric Nanoparticles Containing Methotrexate to Improve Lymphatic Delivery.
Jang JH; Jeong SH; Lee YB
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284483
[TBL] [Abstract][Full Text] [Related]
8. Multi-wall carbon Nanotube surface-based functional nanoparticles for stimuli-responsive dual pharmaceutical compound delivery.
Nabitabar M; Shaterian M; Danafar H; Enhessari M
Sci Rep; 2024 May; 14(1):12073. PubMed ID: 38802442
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel-loaded Bovine Serum Albumin Nanoparticles Conjugated Docosahexaenoic Acid for Inhibiting Lung Cancer Metastasis to Bone.
Zu Y; Hu Y; Yu X; Jiang S
Anticancer Agents Med Chem; 2017; 17(4):542-551. PubMed ID: 27539313
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional nanoparticles from albumin for stimuli-responsive efficient dual drug delivery.
Nosrati H; Abhari F; Charmi J; Davaran S; Danafar H
Bioorg Chem; 2019 Jul; 88():102959. PubMed ID: 31075743
[TBL] [Abstract][Full Text] [Related]
11. Production of biological nanoparticles from bovine serum albumin as controlled release carrier for curcumin delivery.
Salehiabar M; Nosrati H; Javani E; Aliakbarzadeh F; Kheiri Manjili H; Davaran S; Danafar H
Int J Biol Macromol; 2018 Aug; 115():83-89. PubMed ID: 29653171
[TBL] [Abstract][Full Text] [Related]
12. Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations.
Pandey S; Kumar V; Leekha A; Rai N; Ahmad FJ; Verma AK; Talegaonkar S
Pharm Res; 2018 Sep; 35(11):201. PubMed ID: 30187188
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration.
Wang G; Kucharski C; Lin X; Uludağ H
J Drug Target; 2010 Sep; 18(8):611-26. PubMed ID: 20158316
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: microsphere-antibody conjugate.
Muvaffak A; Gurhan I; Gunduz U; Hasirci N
J Drug Target; 2005 Apr; 13(3):151-9. PubMed ID: 16036303
[TBL] [Abstract][Full Text] [Related]
15. Halloysite nanotube-based drug delivery system for treating osteosarcoma.
Sun L; Mills DK
Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():2920-3. PubMed ID: 25570602
[TBL] [Abstract][Full Text] [Related]
16. Development and Characterization of Florfenicol-Loaded BSA Nanoparticles as Controlled Release Carrier.
Arriagada F; Günther G; Zabala I; Rubio-Retama J; Morales J
AAPS PharmSciTech; 2019 May; 20(5):202. PubMed ID: 31140015
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional nanoparticles as somatostatin receptor-targeting delivery system of polyaniline and methotrexate for combined chemo-photothermal therapy.
Nguyen HT; Phung CD; Thapa RK; Pham TT; Tran TH; Jeong JH; Ku SK; Choi HG; Yong CS; Kim JO
Acta Biomater; 2018 Mar; 68():154-167. PubMed ID: 29292170
[TBL] [Abstract][Full Text] [Related]
18. Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier.
Han JH; Oh YK; Kim DS; Kim CK
Int J Pharm; 1999 Oct; 188(1):39-47. PubMed ID: 10528081
[TBL] [Abstract][Full Text] [Related]
19. Synergistic anticancer efficacy of Bendamustine Hydrochloride loaded bioactive Hydroxyapatite nanoparticles: In-vitro, ex-vivo and in-vivo evaluation.
Thomas SC; Sharma H; Rawat P; Verma AK; Leekha A; Kumar V; Tyagi A; Gurjar BS; Iqbal Z; Talegaonkar S
Colloids Surf B Biointerfaces; 2016 Oct; 146():852-60. PubMed ID: 27455405
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate-F127 conjugated mesoporous zinc hydroxyapatite as an efficient drug delivery system for overcoming chemotherapy resistance in osteosarcoma cells.
Meshkini A; Oveisi H
Colloids Surf B Biointerfaces; 2017 Oct; 158():319-330. PubMed ID: 28711857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]